Information  X 
Enter a valid email address

MyCelx Tech. Corp. (MYX)

  Print   

Thursday 14 October, 2021

MyCelx Tech. Corp.

Middle East Contract Win

RNS Number : 0660P
MyCelx Technologies Corporation
14 October 2021
 

14 October 2021

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ("MAR").

 

MYCELX TECHNOLOGIES CORPORATION (AIM: MYX)

 

Middle East Contract Win

 

MYCELX Technologies Corporation ("MYCELX" or the "Company"), the clean water and air technology company transforming the environmental impact of industry, is pleased to announce a second significant contract win in the Middle East this year.

 

This win supplements the four contract renewals awarded year to date and provides further evidence of both an improving market but also the continuing excellence of the MYCELX product suite. MYCELX is the technology of choice as it provides superior performance and reliability, and the Company's expertise and valuable client support has been well-established over the ten years that MYCELX has been operating in Saudi Arabia. Crucially, and in keeping with the relationships in place, it is very cost effective.

 

Once again, MYCELX is providing a clean water solution to a global blue-chip company in a part of the world where water is a scarce commodity. Not only is the business providing the customer with further credentials to allow them to enhance their ESG requirements, but it is also of benefit to the local community.

 

The revenues for this contract of approximately $1million USD will primarily fall in the 2022 financial year and thus provides the Company with further financial visibility.

 

Connie Mixon, CEO of MYCELX, said:

 

"This is a real testament to the hard work and dedication shown by our team in the Middle East as well as the enduring relationships that they have with our customers. We are delighted with this contract and look forward to updating our shareholders with further news in due course."

 

For further information, please contact:  

 

MYCELX Technologies Corporation

Connie Mixon, CEO

Kim Slayton, CFO

 

 

 

Tel: +1 888 306 6843

Canaccord Genuity Limited (Nomad and Sole Broker)

Henry Fitzgerald-O'Connor

Georgina McCooke

 

 

Tel: +44 20 7523 8000

Celicourt Communications (Financial PR)

Mark Antelme

Jimmy Lea

 

Tel: +44 20 8434 2754

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CNTFFMSILEFSESS

a d v e r t i s e m e n t